3-[1-(3-Fluoro-4-methylbenzoyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one

Catalog No. :
ACULGA582
CAS No. :
1775311-27-7
Molecular Formula :
C22H22F2N4O2
Molecular Weight :
412.44

IUPAC Name:5-(1-(3-fluoro-4-methylbenzoyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

3-[1-(3-Fluoro-4-methylbenzoyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[1-(3-Fluoro-4-methylbenzoyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one
IUPAC Name5-(1-(3-fluoro-4-methylbenzoyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
Molecular FormulaC22H22F2N4O2
Molecular Weight412.44
SMILESO=C1N(CC2=CC=C(F)C=C2)C(C3CCN(C(C4=CC=C(C)C(F)=C4)=O)CC3)=NN1
InChI KeyJPRVTCDYILSVFP-UHFFFAOYSA-N
Synonym3-[1-(3-fluoro-4-methylbenzoyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one;3H-1,2,4-Triazol-3-one, 5-[1-(3-fluoro-4-methylbenzoyl)-4-piperidinyl]-4-[(4-fluorophenyl)methyl]-2,4-dihydro-
CAS No.1775311-27-7

Synthetic Route by SureRoute

1. ACULGA582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOLCX984 route compound structure diagram
    ACOLCX98459189-97-8
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACULGA582 route product structure diagram
    ACULGA5821775311-27-7
Inquiry

2. ACULGA582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDIR536 route compound structure diagram
    ACHDIR536350-28-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACULGA582 route product structure diagram
    ACULGA5821775311-27-7
Inquiry

Comments (0)